Corning® Matrigel® Basement Membrane Matrix, Growth Factor Reduced (GFR)

356231 354230 356238 356230 356230 356252 354230 356239 356253
47743-720CS 438.37 USD
47743-722 CACB354230 75796-268 CACB356230 47743-718 75796-272 47743-720 75796-270 75796-274
Corning® Matrigel® Basement Membrane Matrix, Growth Factor Reduced (GFR)
Cell Culture Supplements and Additives
Growth Factor Reduced (GFR) formulation is well suited for applications that require a more highly defined basement membrane preparation

  • Mouse colonies routinely screened for pathogens via Mouse Antibody Production (MAP) testing
  • Extensive PCR testing is performed to screen for a number of pathogens
  • Tested and found negative for bacteria, fungi, and mycoplasma
  • Protein concentrations determined by Lowry method
  • Endotoxin units measured by Limulus Amoebocyte Lysate assay
  • Matrigel Matrix gel stability tested for a period of 14 days at 37°C
  • Biological activity determined for each lot using a neurite outgrowth assay.

Corning Matrigel matrix is a solubilized basement membrane preparation extracted from the Engelbreth-Holm-Swarm (EHS) mouse sarcoma, a tumor rich in extracellular matrix proteins, including Laminin (a major component), Collagen IV, heparin sulfate proteoglycans, entactin/nidogen, and a number of growth factors.

• Cell Growth and Differentiation
• Metabolism/Toxicology Studies
• Invasion Assays
• In Vitro and In Vivo Angiogenesis Assays
• In Vivo Angiogenesis Studies and Augmentation of Tumors in Immunosuppressed Mice

Preparation and Storage
Store at -20°C. Avoid multiple freeze-thaws